Narrow-spectrum β-lactamases being inhibited by clavulanic acid (e.g., TEM-1 and TEM-2; SHV-1) or being resistant to the action of clavulanic acid (e.g., IRT, OXAs) have been reported in Proteus spp.

Emblaveo is now the first and only monobactam/beta-lactamase inhibitor combination antibiotic therapy approved by the regulator for this indication, according to AbbVie. The intravenously-administered ...

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience. [1 ] Department of Ophthalmology, ...

Consider, for example, DAV132: a preparation of activated charcoal designed to bind to and neutralize antibiotics in ... one such compound with narrow-spectrum activity against Acinetobacter ...

Drug utilization study using antibacterial agents consumption data. The groups of antibacterial agents most consumed in the hospital complex were carbapenems, penicillins + beta-lactamase inhibitors, ...

This marks the first approval of a fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic for this indication. AbbVie, a prominent player in the biotechnology industry ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author.

Objective Antimicrobial stewardship (AMS) significantly reduces inappropriate antibiotic use and improves patient outcomes ... We assessed parameter uncertainty using deterministic and probabilistic ...

The official React Native and Expo components for Stream Chat, a service for building chat applications.

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...